• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Acute coronary syndromes: summary of updated NICE guidance.

作者信息

Corbett Simon J, Ftouh Saoussen, Lewis Sedina, Lovibond Kate

机构信息

University Hospital Southampton NHS Foundation Trust, Southampton, UK

National Guideline Centre, Royal College of Physicians, London, UK.

出版信息

BMJ. 2021 Jan 15;372:m4760. doi: 10.1136/bmj.m4760.

DOI:10.1136/bmj.m4760
PMID:33452009
Abstract
摘要

相似文献

1
Acute coronary syndromes: summary of updated NICE guidance.急性冠状动脉综合征：英国国家卫生与临床优化研究所（NICE）最新指南总结
BMJ. 2021 Jan 15;372:m4760. doi: 10.1136/bmj.m4760.
2
Physician and Hospital Utilization of P2Y12 Inhibitors in ST-Segment-Elevation Myocardial Infarction in the United States: A Study From the National Cardiovascular Data Registry's Research to Practice Initiative.美国ST段抬高型心肌梗死患者中P2Y12抑制剂的医生及医院使用情况：一项来自国家心血管数据注册中心“研究到实践”倡议的研究
Circ Cardiovasc Qual Outcomes. 2020 Mar;13(3):e006275. doi: 10.1161/CIRCOUTCOMES.119.006275. Epub 2020 Mar 11.
3
Secondary prevention of acute coronary events with antiplatelet agents (SPACE-AA): One-year real-world effectiveness and safety cohort study in the French nationwide claims database.抗血小板药物二级预防急性冠脉事件（SPACE-AA）：法国全国索赔数据库中的一年真实世界有效性和安全性队列研究。
Atherosclerosis. 2019 Feb;281:98-106. doi: 10.1016/j.atherosclerosis.2018.11.037. Epub 2018 Dec 7.
4
Prasugrel or ticagrelor relative to clopidogrel in triple-antiplatelet treatment combined with glycoprotein IIb/IIIa inhibitor for patients with STEMI undergoing PCI: a meta-analysis.替格瑞洛或普拉格雷与氯吡格雷三联抗血小板治疗联合糖蛋白 IIb/IIIa 抑制剂用于接受 PCI 的 STEMI 患者：一项荟萃分析。
BMC Cardiovasc Disord. 2020 Mar 12;20(1):130. doi: 10.1186/s12872-020-01403-6.
5
[The ISAR-REACT 5 trial: is there a winner between prasugrel and ticagrelor in acute coronary syndromes?].[ISAR-REACT 5试验：在急性冠状动脉综合征中，普拉格雷和替格瑞洛谁更胜一筹？]
G Ital Cardiol (Rome). 2020 Mar;21(3):171-174. doi: 10.1714/3306.32764.
6
Long versus short dual antiplatelet therapy in acute coronary syndrome patients treated with prasugrel or ticagrelor and coronary revascularization: Insights from the RENAMI registry.接受普拉格雷或替格瑞洛治疗的急性冠脉综合征患者中长程与短程双联抗血小板治疗与冠状动脉血运重建：来自 RENAMI 注册研究的结果。
Eur J Prev Cardiol. 2020 May;27(7):696-705. doi: 10.1177/2047487319836327. Epub 2019 Mar 12.
7
Prasugrel (Efient®) with percutaneous coronary intervention for treating acute coronary syndromes (review of TA182): systematic review and economic analysis.普拉格雷（Efient®）联合经皮冠状动脉介入治疗急性冠状动脉综合征（TA182综述）：系统评价与经济学分析
Health Technol Assess. 2015 Apr;19(29):1-130. doi: 10.3310/hta19290.
8
Safety and Efficacy in Prasugrel- Versus Ticagrelor-Treated Patients With ST-Elevation Myocardial Infarction.替格瑞洛与普拉格雷治疗 ST 段抬高型心肌梗死患者的安全性和疗效。
J Cardiovasc Pharmacol. 2018 Oct;72(4):186-190. doi: 10.1097/FJC.0000000000000609.
9
Refining percutaneous coronary intervention: intracoronary imaging, haemodynamics, P2Y12 antagonists, and public outcomes reporting.优化经皮冠状动脉介入治疗：冠状动脉内成像、血流动力学、P2Y12拮抗剂及公共结果报告。
Eur Heart J. 2019 Aug 14;40(31):2549-2552. doi: 10.1093/eurheartj/ehz590.
10
Prescription Patterns of Clopidogrel, Prasugrel, and Ticagrelor After Percutaneous Coronary Intervention With Stent Implantation (from the NCDR PINNACLE Registry).经皮冠状动脉介入治疗（支架植入术）后氯吡格雷、普拉格雷和替格瑞洛的处方模式（来自 NCDR PINNACLE 注册研究）。
Am J Cardiol. 2019 Dec 15;124(12):1807-1812. doi: 10.1016/j.amjcard.2019.09.003. Epub 2019 Sep 26.

引用本文的文献

1
GPD2 inhibition impairs coagulation function via ROS/NF-κB/P2Y12 pathway.GPD2抑制通过ROS/NF-κB/P2Y12途径损害凝血功能。
Cell Mol Biol Lett. 2025 Jul 18;30(1):84. doi: 10.1186/s11658-025-00759-x.
2
In-Hospital Mortality and Treatment in Patients With Acute Coronary Syndrome With and Without Standard Modifiable Cardiovascular Risk Factors: Findings From the CCC-ACS Project.急性冠状动脉综合征患者伴或不伴可标准修正的心血管风险因素的住院死亡率和治疗：CCC-ACS 项目的结果。
J Am Heart Assoc. 2024 Oct;13(19):e029252. doi: 10.1161/JAHA.122.029252. Epub 2024 Sep 18.
3
Effects of different rehabilitation modality on cardiopulmonary function in patients with acute coronary syndrome after revascularization.
不同康复方式对急性冠脉综合征患者血运重建术后心肺功能的影响。
Front Cardiovasc Med. 2024 Mar 4;10:1120665. doi: 10.3389/fcvm.2023.1120665. eCollection 2023.
4
Predictors of left ventricular ejection fraction in high-risk percutaneous coronary interventions.高危经皮冠状动脉介入治疗中左心室射血分数的预测因素
Front Cardiovasc Med. 2024 Feb 2;11:1342409. doi: 10.3389/fcvm.2024.1342409. eCollection 2024.
5
2023 TAMIS/TSOC/TACVPR Consensus Statement for Patients with Acute Myocardial Infarction Rehabilitation.2023年急性心肌梗死康复患者的经肛门微创手术/经括约肌间切除术/经肛门腔镜下全直肠系膜切除术共识声明
Acta Cardiol Sin. 2023 Nov;39(6):783-806. doi: 10.6515/ACS.202311_39(6).20230921A.
6
Habitual physical activity improves outcomes among patients with myocardial infarction.习惯性体育活动可改善心肌梗死患者的预后。
Front Cardiovasc Med. 2023 Jun 12;10:1174466. doi: 10.3389/fcvm.2023.1174466. eCollection 2023.
7
Personalized Dual Antiplatelet Therapy in Acute Coronary Syndromes: Striking a Balance Between Bleeding and Thrombosis.急性冠状动脉综合征的个体化双联抗血小板治疗：在出血和血栓形成之间取得平衡。
Curr Cardiol Rep. 2023 Jul;25(7):693-710. doi: 10.1007/s11886-023-01892-9. Epub 2023 Jun 1.
8
[Severe rhabdomyolysis associated with atorvastatin. Case report].[与阿托伐他汀相关的严重横纹肌溶解症。病例报告]
Rev Med Inst Mex Seguro Soc. 2023 Mar 1;61(2):245-250.
9
Safety and Efficacy of Ticagrelor versus Clopidogrel in East Asian Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention Treated with Dual Antiplatelet Therapy: A Meta-Analysis of Randomized Controlled Trials.替格瑞洛与氯吡格雷用于东亚行经皮冠状动脉介入治疗的急性冠状动脉综合征患者双联抗血小板治疗的安全性和有效性：一项随机对照试验的荟萃分析。
Cardiology. 2023;148(4):363-373. doi: 10.1159/000530602. Epub 2023 Apr 24.
10
Use of machine learning models to predict in-hospital mortality in patients with acute coronary syndrome.使用机器学习模型预测急性冠状动脉综合征患者的院内死亡率。
Clin Cardiol. 2023 Feb;46(2):184-194. doi: 10.1002/clc.23957. Epub 2022 Dec 7.